MANDAS, ANTONELLA
 Distribuzione geografica
Continente #
EU - Europa 153.346
NA - Nord America 8.550
AS - Asia 4.003
SA - Sud America 477
Continente sconosciuto - Info sul continente non disponibili 474
AF - Africa 99
OC - Oceania 22
Totale 166.971
Nazione #
IT - Italia 150.679
US - Stati Uniti d'America 8.401
SG - Singapore 1.529
CN - Cina 1.366
UA - Ucraina 646
SE - Svezia 482
DE - Germania 360
BR - Brasile 359
VN - Vietnam 347
GB - Regno Unito 286
FI - Finlandia 284
FR - Francia 236
HK - Hong Kong 152
IN - India 126
BD - Bangladesh 110
NL - Olanda 99
KR - Corea 82
CA - Canada 77
RU - Federazione Russa 56
AR - Argentina 39
JP - Giappone 37
PL - Polonia 36
EC - Ecuador 30
IQ - Iraq 30
ES - Italia 27
TR - Turchia 26
ZA - Sudafrica 25
AT - Austria 24
IR - Iran 23
MX - Messico 22
BE - Belgio 21
IE - Irlanda 21
PH - Filippine 18
PK - Pakistan 18
AU - Australia 17
ID - Indonesia 16
JM - Giamaica 15
MA - Marocco 15
SA - Arabia Saudita 15
MY - Malesia 14
NG - Nigeria 14
UZ - Uzbekistan 14
CH - Svizzera 13
EG - Egitto 13
TH - Thailandia 13
CO - Colombia 12
AL - Albania 10
GR - Grecia 9
OM - Oman 9
VE - Venezuela 9
LT - Lituania 8
CL - Cile 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
NP - Nepal 6
SV - El Salvador 6
TN - Tunisia 6
TW - Taiwan 6
ET - Etiopia 5
LB - Libano 5
NZ - Nuova Zelanda 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AZ - Azerbaigian 4
BH - Bahrain 4
CY - Cipro 4
HN - Honduras 4
HR - Croazia 4
LV - Lettonia 4
MU - Mauritius 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
KE - Kenya 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
PT - Portogallo 3
RS - Serbia 3
SN - Senegal 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
Totale 166.480
Città #
Cagliari 144.238
Uta 3.872
Singapore 842
Ashburn 735
Chandler 587
Fairfield 557
San Jose 541
Woodbridge 511
Ann Arbor 477
Boardman 454
Dallas 438
Jacksonville 349
Houston 335
Nyköping 290
Wilmington 283
Seattle 243
Council Bluffs 234
Beijing 210
Cambridge 200
Milan 196
Rome 186
Helsinki 176
Hefei 171
Hong Kong 140
Los Angeles 140
Santa Clara 133
Dearborn 127
Nanjing 105
Boston 101
Ho Chi Minh City 101
Lauterbourg 93
New York 90
Shanghai 82
Seoul 69
Hanoi 68
Verona 67
Sassari 64
Naples 62
Columbus 60
Buffalo 56
Dong Ket 46
São Paulo 45
Turin 45
The Dalles 44
Bari 41
Shenyang 40
Frankfurt am Main 39
Hebei 34
San Diego 33
Chicago 32
Nanchang 32
Jiaxing 31
London 29
Munich 29
Redwood City 29
Changsha 28
Pune 27
Zhengzhou 27
Tianjin 26
Tokyo 26
Guangzhou 25
Redondo Beach 25
Washington 25
Brooklyn 24
Atlanta 23
Orem 23
Toronto 23
Warsaw 22
Phoenix 20
Brussels 19
Genoa 19
Catania 18
Da Nang 18
Jinan 18
Nuremberg 18
Orange 18
Rio de Janeiro 18
Amsterdam 17
Baghdad 17
Chennai 17
Montreal 17
Bay Shore 16
Bologna 16
Brescia 16
Denver 16
Mountain View 16
Mumbai 16
Auburn Hills 15
Norwalk 15
Florence 14
Hangzhou 13
Palermo 13
Porto Torres 13
Wuhan 13
Dublin 12
Guayaquil 12
Haiphong 12
Quito 12
Stockholm 12
Gravina In Puglia 11
Totale 159.053
Nome #
null 3.998
Cognitive decline and depressive symptoms in late-life are associated with statin use: evidence from a population-based study of Sardinian old people living in their own home 3.404
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.206
null 3.087
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 3.037
null 2.985
null 2.897
Abnormal lipid accumulation and cluster formation of naive peripheral blood mononuclear cells: a useful tool for early detection of central nervous system damage in elderly 2.888
Resting-state functional connectivity MRI analysis in Human Immunodeficiency Virus and Hepatitis C Virus co-infected subjects. A pilot study 2.826
The venous thromboembolic risk and the clot wave analysis: a useful relationship? 2.776
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.675
ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep 2.672
The natural course of chronic HBsAg positive hepatitis with serum HBV-DNA and anti-HBe in Sardinia 2.603
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.501
Oxidative Imbalance in HIV-1 Infected Patients Treated with Antiretroviral Therapy 2.450
null 2.446
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.299
null 2.280
null 2.267
Thalassemia intermedia is associated with a proatherogenic biochemical phenotype 2.158
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.133
null 2.100
Physical Performance and Falling Risk Are Associated with Five-Year Mortality in Older Adults: An Observational Cohort Study 2.083
null 2.030
null 1.971
Epidemiology of HDV infection in Sardinia, an island with a high endemicity for HBV: A multicenter study 1.918
null 1.848
Studio ecografico dei linfonodi del legamento epatoduodenale in pazienti con epatite cronica virale 1.817
New method for early detection of CNS damage in elderly subjects: abnormal lipid accumulation and cluster formation in naive PBMCs 1.799
null 1.769
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study 1.715
Molecular epidemiology of intrafamilial transmission of hepatitis C virus: A controlled study 1.662
null 1.660
Multidimensional geriatric assessment in elderly HIV patients 1.635
null 1.601
Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections 1.578
null 1.527
RBANS: un valido strumento di valutazione cognitiva in soggetti HIV-infetti in cART = RBANS: a valid tool for cognitive assessment of HIV-infected people on cART 1.500
The Role of Peripheral Cells in Neurocognitive Disorders Detection 1.467
null 1.450
[Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections]. FT Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell'eroina e con altre infezioni virali. 1.379
Prevalenza e caratteristiche cliniche dell’infezione delta in emodializzati portatori cronici di HBsAg 1.370
null 1.355
The hidden treasure of 24-hours ambulatory blood pressure monitoring—Assessing BP variability 1.338
null 1.320
The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders 1.310
Prevalence and clinical significance of serum HBV-DNA in the course of anti-HBe positive chronic hepatitis B in Sardinia 1.302
Correlation between depressive symptoms and cognitive impairment and use of hmg-coa reductase inhibitors in a group of elderly subjects evaluated in their own homes 1.272
Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells 1.247
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 1.226
Epidemiologia dell’infezione da HIV a Cagliari: studio multicentrico 1.203
Prevalenza e significato clinico dell’HBV-DNA nel siero dei portatori cronici di HBsAg/anti-HBe positivi in Sardegna 1.174
null 1.158
Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell’eroina e con altre infezioni virali 1.143
null 1.112
Epidemiologic patterns of infection with HIV in Sardinia. A multicentre study 1.111
Emergency department: risk stratification in the elderly 1.039
null 1.003
Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population 1.002
High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment 963
Valutazione multidimensionale geriatrica: confronto tra un gruppo di anziani valutati ambulatorialmente e un gruppo di anziani valutati a domicilio 927
null 919
null 915
null 914
Comprehensive Geriatric Assessment: Application and correlations in a real-life cross-sectional study 883
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 854
null 803
null 742
Mini-Mental State Examination: Optimal Cut-Off Levels for Mild and Severe Cognitive Impairment 742
null 706
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 692
Long-term effect of lymphoblastoid interferon therapy of anti-HBe and HBV-DNA positive chronic hepatitis B 686
How to evaluate Quality of Life 683
null 683
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 636
Association between Depressive Mood, Antidepressant Therapy and Neuropsychological Performances: Results from a Cross-Sectional Study on Elderly Patients 634
Cognitive assessment with neurocognitive screening tools 626
Favourable response to lymphoblastoid interferon of anti-HBe positive chronic Hepatitis type B 611
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 603
Valutazione multidimensionale geriatrica di un gruppo di anziani ultraottantacinquenni studiati nel proprio domicilio 602
Diabetes mellitus, malnutrition, and sarcopenia: The bond is not explained by bioelectrical impedance analysis in older adults 591
MMSE e MODA due metodiche a confronto nello screening del deficit cognitivo nel soggetto anziano valutato sul territorio: dati preliminari 588
Nutritional Status and Potentially Inappropriate Medications in Elderly: Real-World Experience 577
Treatment of chronic delta hepatitis with higt and low doses of interferon alpha-2a. A randomizzed controlled trial 576
Fragilità: confronto tra un gruppo di anziani valutati nel proprio domicilio e un gruppo di anziani valutati ambulatorialmente 551
Valutazione multidimensionale di una popolazione di anziani fragili: correlazione del PPT con le altre aree dimensionali 549
Cholesterol esterification as a mediator of proliferation of vascular smooth muscle cells and peripheral blood mononuclear cells during atherogenesis 537
Valutazione dello stato nutrizionale di una popolazione di soggetti anziani: correlazione del MNA con altre aree dimensionali 537
The response to lymphoblastoid interferon of anti-HBe and HBV-DNA positive patients with chronic hepatitis B 533
STOPP/START antiaggregation and anticoagulation alerts in atrial fibrillation 531
Variazioni della massa ossea nei pazienti con b Talassemia major in trattamento con calcio, Vitamina D e bisfosfonati. 530
null 528
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 527
L'Interferone nella terapia dell’epatite cronica delta 522
Anemia in Elderly Patients-The Impact of Hemoglobin Cut-Off Levels on Geriatric Domains 521
Randomized controlled trial of high and low doses of interferon (IFN) alpha-2a (Roferon-A) in chronic HDV hepatitis 518
Orthogeriatric Assessment of the Elderly Patient with Fragility Hip Fracture: Preliminary Results of a Prospective Study 517
Valutazione multidimensionale: monitoraggio della fragilità in un gruppo di soggetti ultrasessantacinquenni 517
Efficacia e tollerabilità della terapia antiretrovirale altamente attiva (HAART) negli over 60: descrizione di 3 casi clinici 516
Anti-HBe and HBV-DNA positive chronic hepatiis B: response to interferon therapy 506
Totale 140.378
Categoria #
all - tutte 214.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 214.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.718 0 676 614 438 596 555 637 525 645 869 969 1.194
2022/202312.819 1.364 1.702 1.638 1.028 1.067 1.234 560 827 786 891 1.019 703
2023/202415.146 614 615 509 874 1.438 2.704 2.777 994 674 1.145 1.438 1.364
2024/202531.414 6.890 8.509 4.281 3.782 2.367 1.737 2.554 169 324 211 277 313
2025/20268.659 570 479 880 457 617 533 1.112 935 919 887 612 658
2026/2027772 293 479 0 0 0 0 0 0 0 0 0 0
Totale 166.971